Therapeutic Classification

cns stimulant Registry

Clinical reference for cns stimulant medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (cns stimulant)

Medication	Therapeutic Class	Maternal Safety
AMPHETAMINE MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.	CNS Stimulant	avoid
AMPHETAMINE SULFATE MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.	CNS Stimulant	avoid
ARMODAFINIL Induces CYP3A4 and inhibits CYP2C19 affecting many drugs Can cause serious skin reactions and psychiatric symptoms.	CNS Stimulant	caution
DEXMETHYLPHENIDATE HYDROCHLORIDE MAOIs are contraindicated due to risk of hypertensive crisis May exacerbate pre-existing psychosis and cause peripheral vasculopathy.	CNS Stimulant	safe
DEXTROAMPHETAMINE SULFATE MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.	CNS Stimulant	avoid
METHAMPHETAMINE HYDROCHLORIDE MAOIs can cause hypertensive crisis Alkalinizing agents increase urinary excretion and acidifying agents decrease it High potential for abuse and dependence.	CNS Stimulant	avoid
METHYLPHENIDATE MAOIs are contraindicated due to risk of hypertensive crisis May exacerbate pre-existing psychosis and cause peripheral vasculopathy.	CNS Stimulant	safe
MODAFINIL Induces CYP3A4 and inhibits CYP2C19 affecting many drugs Can cause serious skin reactions and psychiatric symptoms.	CNS Stimulant	caution

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.